Literature DB >> 3690840

Non-enzymic glycation of individual plasma proteins in normoglycemic and hyperglycemic patients.

G E Austin1, R H Mullins, L G Morin.   

Abstract

Diabetic patients in poor glycemic control show increased glycation of total plasma proteins, but little is yet known about the relative extents to which the various individual proteins are glycated. Thus, we studied the non-enzymic glycation of several major plasma proteins and plasma protein fractions in normal and diabetic patients. In vivo glycation for most plasma proteins was very low in non-diabetic patients, only gamma globulin showing more than 5% glycation. In diabetic plasmas, glycation was much greater, immunoglobulins again showing the greatest proportion, followed in descending order by albumin, complement C3, fibrinogen, transferrin, haptoglobin, and alpha-1-antitrypsin. When plasma proteins were glycated in vitro, this order was IgG greater than complement C3 greater than albumin greater than transferrin greater than haptoglobin greater than alpha-1-antitrypsin. In general, proteins with the longest biological half-lives, such as IgG and albumin, showed the greatest in vivo glycation. On the other hand, proteins with high intrinsic glycability, such as complement C3, showed moderate glycation, despite a short half-life. Except for albumin, more basic proteins showed greater glycation than acidic proteins, but there was poor correlation between mole percent lysine and glycation. Evidently the relative extents of glycation of different plasma proteins are a complex function of integrated glucose concentrations over time and of the half-life and chemical characteristics of each protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3690840

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  25 in total

Review 1.  Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes.

Authors:  Gabriella Fleixo-Lima; Hilla Ventura; Michal Medini; Liliana Bar; Pnina Strauss; Eli C Lewis
Journal:  J Diabetes Sci Technol       Date:  2014-08-25

2.  HPLC assay for serum glycated albumin.

Authors:  E Vorberg
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

3.  Caution: interpretation of results of HPLC assay for serum glycated albumin.

Authors:  M P Cohen
Journal:  Diabetologia       Date:  1991-10       Impact factor: 10.122

4.  Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects.

Authors:  Catherine S Davies; Claire L Harris; B Paul Morgan
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

5.  Impact of glycation on antibody clearance.

Authors:  Jane Yang; Ronya Primack; Mike Frohn; Wei Wang; Peng Luan; Marc W Retter; Gregory C Flynn
Journal:  AAPS J       Date:  2014-11-21       Impact factor: 4.009

6.  The performance of glycated albumin as a biomarker of hyperglycemia and cardiometabolic risk in children and adolescents in the United States.

Authors:  Amelia S Wallace; Mary R Rooney; Tammy M Brady; Justin B Echouffo-Tcheugui; Robert Christenson; Morgan E Grams; Elizabeth Selvin
Journal:  Pediatr Diabetes       Date:  2021-12-26       Impact factor: 4.866

Review 7.  Targeted complement inhibition as a promising strategy for preventing inflammatory complications in hemodialysis.

Authors:  Robert A DeAngelis; Edimara S Reis; Daniel Ricklin; John D Lambris
Journal:  Immunobiology       Date:  2012-11       Impact factor: 3.144

8.  Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes.

Authors:  Saori Maruo; Koka Motoyama; Tomoe Hirota; Yoshinori Kakutani; Yuko Yamazaki; Tomoaki Morioka; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Masanori Emoto
Journal:  Diabetol Int       Date:  2020-03-21

9.  Complement C3: an emerging risk factor in cardiometabolic disease.

Authors:  E Hertle; M M J van Greevenbroek; C D A Stehouwer
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

10.  Serum glycated albumin is inversely influenced by fat mass and visceral adipose tissue in Chinese with normal glucose tolerance.

Authors:  Feifei Wang; Xiaojing Ma; Yaping Hao; Rong Yang; Jie Ni; Yunfeng Xiao; Junling Tang; Yuqian Bao; Weiping Jia
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.